R&D Data

R＆D Expenditure

Consolidated (Ratio of Expenses to Total Sales)

  • FY 20 Sales Revenue: ¥2,287.0 billion, R&D expenditures: ¥178.7 billion; FY 21 Sales Revenue: ¥2,765.3 billion, R&D expenditures: ¥174.9 billion; FY 22 Sales Revenue: ¥2,895.3 billion, R&D expenditures: ¥195.6 billion; FY 23 Sales Revenue: ¥2,446.9 billion, R&D expenditures: ¥184.0 billion; FY 24 Sales Revenue: ¥2,606.3 billion, R&D expenditures: ¥145.2 billion;FY 25 Sales Revenue: ¥2,328.5 billion, R&D expenditures: ¥144.7 billion

Human Resources Engaged in R&D

Consolidated

  • FY 20: 4,372 persons, FY 21: 4,223 persons, FY 22: 4,213 persons, FY 23: 3,546 persons, FY24: 3,296 persons, FY25: 3,251 persons,

Domestic Patent Applications

  • FY 20: 1,125; FY 21: 1,061; FY 22: 1,152; FY 23: 1,158, FY 24: 1,086; FY 25: 1,018;

Major Publications and Verbal Presentations

  • FY 20 overseas: 16, domestic 49; FY 21 overseas: 11, domestic 85; FY 22 overseas: 35, domestic 66; FY 23 overseas: 34, domestic: 57, FY 24 overseas: 34, domestic: 62; FY 25 overseas: 53, domestic: 82;

R&D